// App-Quantinova.ai

THU0251 : IMMUNOPHENOTYPIC CLUSTERS OF SLE PATIENTS REVEAL SUBGROUPS WITH SEVERE DISEASE RESISTANT TO CONVENTIONAL THERAPY

Researchers

Presenter

  • A. Psarras

Principal Investigators

  • D. Li

  • A. Alase

  • Z. Wigston

  • I. Bruce

  • N. Mchugh

  • E. Vital

Medical Centers

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • University of Bath, Bath, United Kingdom

  • University of Manchester, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Mycophenolic acid

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Genzyme

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved